(Q39614358)

13 September 2017

1 reference

title

Cutaneous reactions to nonsteroidal anti-inflammatory drugs. A review (English)

1 reference

13 September 2017

Bigby M

1

1 reference

13 September 2017

Stern R

series ordinal

2

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 May 1985

1 reference

Journal of the American Academy of Dermatology

13 September 2017

published in

1 reference

13 September 2017

volume

12

1 reference

13 September 2017

issue

5 Pt 1

1 reference

13 September 2017

page(s)

866-876

1 reference

Drug therapy: nonsteroidal antiinflammatory drugs (first of two parts).

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Nonsteroidal antiinflammatory drugs (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Antirheumatic drugs: clinical pharmacology and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Adverse reactions to non-steroidal antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Drug reactions. XII. Cutaneous reactions to anti-rheumatic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

SALICYLATE THERAPY IN RHEUMATOID ARTHRITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Cutaneous responses to aspirin and its derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Hypersensitivity to nonsteroidal antiinflammatory drugs: Indications and methods for oral challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Effect of salicylates in urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

1 reference

7 January 2021

Diflunisal in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Comparison of diflunisal and acetylsalicylic acid in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Chemical and Pharmacological Properties of Diflunisal.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Acute renal failure associated with diflunisal

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Acute interstitial nephritis and erythroderma associated with diflunisal

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Diflunisal and Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Indomethacin in the treatment of rheumatoid arthritis. A controlled trial comparing indomethacin, phenylbutazone, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Hyperuricemia and gout. Classification, complications and management

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Side-effects of indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Indomethacin, Reduced Retinal Sensitivity, and Corneal Deposits

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Non-thrombocytopenic purpura and acute glomerulonephritis after indomethacin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

A case of toxic epidermal necrolysis secondary to indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Sulindac. Trials of a new anti-inflammatory drug

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Severe reaction associated with sulindac administration

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Agranulocytosis and sulindac

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Sulindac-induced anaphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Unusual pernio‐like reaction to sulindac

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Tolmetin-induced anaphylactoid reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Nephrotic Syndrome Induced by Tolmetin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Cimetidine plus propantheline for chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Evaluation of the Analgesic Properties of Zomepirac

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Anaphylactic-like reactions to zomepirac

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Zomepirac-induced serum sickness. A report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

1 reference

7 January 2021

Ibuprofen-induced meningitis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Ocular side-effects of Ibuprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Renal papillary necrosis due to ibuprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Alopecia Associated With Ibuprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

The effect of naproxen-sodium on the prostaglandin concentrations of the menstrual blood and uterine “jet-washings” in dysmenorrehic women

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Naproxen Metabolism in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Naproxen: Long-Term Study in Rheumatoid Arthritis and “Placebo Pulse”

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Naproxen-induced lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Jaundice associated with the use of benoxaprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Fatal cholestatic jaundice in elderly patients taking benoxaprofen.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Leukotrienes and Other Lipoxygenase Products in the Pathogenesis and Therapy of Psoriasis and Other Dermatoses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Benoxaprofen: side-effect profile in 300 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Benoxaprofen-induced photo-onycholysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Benoxaprofen: a new arthritis medication that causes phototoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Phototoxicity from benoxaprofen: in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

A study of benoxaprofen-induced photosensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Association between Stevens-Johnson syndrome and benoxaprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Association between Stevens-Johnson syndrome and benoxaprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Toxic epidermal necrolysis, leucopenia and thrombocytopenic purpura--a further complication of Benoxaprofen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Treatment of nodular prurigo with benoxaprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Mefenamic acid overdosage

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Avoidance of mefenamic acid in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Genetic predictors of patient response and side effects in the treatment of rheumatoid arthritis with a high dose nonsteroidal antiinflammatory drug regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Aplastic anaemia associated with piroxicam

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Breast cancer and cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Piroxicam-induced photosensitivity. In vivo and in vitro studies of its photosensitizing potential

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Reversible overt nephropathy with Henoch-Schönlein purpura due to piroxicam

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Pindolol and hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Phenylbutazone liver injury: A clinical-pathologic survey of 23 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Hypersensitivity reactions to phenylbutazone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

Drugs causing fixed eruptions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2970110-7

7 January 2021

10.1016/S0190-9622(85)70110-7

Identifiers

DOI

0 references

1 reference